MGB Wealth Management LLC Reduces Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

MGB Wealth Management LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 29.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,793 shares of the healthcare conglomerate’s stock after selling 1,157 shares during the quarter. MGB Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,418,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently bought and sold shares of UNH. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group in the 4th quarter worth $30,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group in the third quarter valued at $37,000. Friedenthal Financial acquired a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $51,000. Highline Wealth Partners LLC acquired a new position in UnitedHealth Group during the 3rd quarter worth $55,000. Finally, Legacy Investment Solutions LLC bought a new position in UnitedHealth Group in the 3rd quarter valued at about $57,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Truist Financial reduced their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Barclays decreased their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $527.31 on Thursday. The company has a market cap of $485.27 billion, a PE ratio of 34.02, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average price is $526.25 and its two-hundred day moving average price is $563.96. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $5.83 earnings per share. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. 0.33% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.